Search

everythinglearnresearchcommunity

for

Search:↓

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

Early balding at 40 increases prostate cancer risk.

Androgen receptor inactivation delays skin cancer onset and reduces incidence in mice, with gender differences in susceptibility.

Early balding, especially frontal, increases prostate cancer risk; more research needed.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

Higher DHT in male baldness may protect against prostate cancer.

Finasteride for hair loss is safe and does not increase the risk of high-grade prostate cancer.

Male pattern baldness might have evolved to help protect against prostate cancer by increasing UV radiation on the scalp.

Baldness, especially at the front, may lower the risk of testicular cancer by 31%, but its link to prostate cancer is unclear.

Men with male pattern baldness may have a slightly higher risk of prostate cancer.

Men with early balding showed higher levels of certain genes linked to hair loss and possibly prostate cancer.

Extracellular vesicles and androgen receptors may help identify prostate cancer resistance and reduce SARS-CoV-2 infection.

Swedish men with the E213 A-allele of the androgen receptor have a lower risk of prostate cancer.

The document suggests more research is needed to understand the link between baldness and prostate cancer.

Finasteride treats hair loss and reduces prostate cancer risk.

The study found no link between baldness patterns and androgen levels in men with benign prostate enlargement or prostate cancer.

Baldness (androgenic alopecia) could be a risk factor for prostate cancer.

Baldness at age 40 is not linked to a higher risk of aggressive prostate cancer.

Hair loss gene linked to prostate issues.

Monascus helps prevent baldness, prostate issues, and may be a natural alternative to medications.

Researchers found four natural compounds that can change DHT levels in prostate cancer cells.

Male pattern baldness does not cause an increased risk of prostate cancer.

Men with baldness on the top of their head might have a small increased risk of prostate cancer.

There might be a link between male pattern baldness and a higher risk of prostate cancer and testicular cancer.

Gene variant linked to prostate cancer, hormone levels, and hair loss.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

ERG increases SOX9, promoting prostate cancer growth and invasion.